Skip to main content
Clinical Trials/KCT0004466
KCT0004466
Completed
未知

To evaluate and compare the efficacy of 18F-FDG PET taken in hyperglycemic state, 18F-FDG PET taken in NPO state, and C-11 acetate PET in detecting and grading brain tumor

ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
73
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 21, 2020
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult men and women over the age of 20
  • 2\. First diagnosed primary brain tumor patient
  • 3\. Patients scheduled to undergo cancer resection as their primary treatment

Exclusion Criteria

  • 1\. Patients who have undergone chemotherapy or radiation therapy for pretreatment
  • 2\. A pregnant patient
  • 3\. Patients or guardians who do not understand or do not accept consent
  • 4\. Uncontrolled diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PILOT STUDY ASSESSING THE EFFECTIVENESS OF 18FDG PET-CT IN THE EARLY DIAGNOSIS OF BREAST CANCER AND / OR OVARIAN CANCER IN WOMEN BRCA1 or BRCA 2 MUTATION CARRIERSBreast cancer screening in women BRCA1 or BRCA2 mutation.Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-023935-41-ESConsorcio de Apoyo a la Investigación Biomédica en Red (CAIBER)234
Completed
Not Applicable
Assessing the efficacy of FDG-PET(18F-fluorodeoxy glucose positron emission tomography) in the early detection of RCC (Renal cell carcinoma) in patients with ESRD(End stage renal disease)Renal cell carcinoma related with end stage renal disease
JPRN-UMIN000009336Gunma University Hospital department of nuclear medecine150
Completed
Not Applicable
Comparison diagnostic performance of 18F-Flurodeoxyglucose and 18F-Floroestradiol Positron Emission Tomography/Computed Tomography for Initial Staging in Estrogen Receptor Positive Breast Cancer Patients.Initial staging in ER-positive breast cancer18F-FDG, 18F-FES, 18F-Fluorodeoxyglucose, 18F-Fluroestradiol, ER-positive breast cancer
TCTR20230603002ational Cyclotron and PET Centre, Chulabhorn Hospital206
Recruiting
Not Applicable
A comparative study of F-18 FBPA-PET and F-18 FDG-PET in head and neck cancerHead and neck cancer
JPRN-UMIN000049242Osaka University Graduate School of Medicine85
Recruiting
Not Applicable
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant glioma
JPRN-UMIN000035976Southern TOHOKU BNCT Research Center20